跳至主要内容
临床试验/NCT04847271
NCT04847271已完成不适用

Implementation of Physical Activity on Prescription for Children With Obesity in Paediatric Health Care (IMPA): a Feasibility Study

Vastra Gotaland Region1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2022年2月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
42
试验地点
1
主要终点
Change in physical activity level

研究概览

简要总结

Background: physical inactivity is a main cause of childhood obesity. Physical activity on prescription (PAP) is an evidence-based intervention for adults, but has not been evaluated in children with obesity.

Aim: to evaluate the feasibility of a PAP intervention for children with obesity by assessing both clinical patient outcomes and implementation outcomes.

Method: a single-arm clinical trial in which children with obesity participate in a 4-month PAP intervention. Measurement points are baseline and 4 months, with long-term follow-ups at 8 and 12 months.

Population: children with obesity.

Intervention: physical activity on prescription (PAP).

Patient outcomes: physical activity level/pattern (including sedentary time), BMI, waist circumference, metabolic risk markers, health-related quality of life, self-efficacy for physical activity, motivation for physical activity.

Implementation outcomes: coherence, cognitive participation, collective action, and reflexive monitoring in relation to PAP (the four core constructs of the Normalization Process Theory); appropriateness, acceptability and feasibility of PAP; barriers and facilitators for implementing PAP; recruitment and attrition rates, and intervention fidelity and adherence.

详细描述

Physical inactivity is a main cause of childhood obesity which tracks into adulthood obesity, making it important to address early in life. Physical activity on prescription (PAP) is an evidence-based intervention developed in Sweden that has shown good effect on physical activity levels in adults, but has not been evaluated in children with obesity. This clinical study is nested in a larger research project aiming to assess the prerequisites, determinants, and feasibility of implementing PAP adapted to children with obesity in paediatric health care. Children's and parents' experiences of participating in the PAP intervention will also be explored.

In a first, pre-clinical trial, phase, healthcare providers and managers from 26 paediatric clinics in Region Västra Götaland, Sweden, will participate in a web-based survey, and a subset of this sample in a focus group study. Findings from these two data collections will form the basis for further development and adaptation of PAP to the target group and context.

In the project's second phase, this adapted PAP intervention will be evaluated in a clinical study in a sample of approximately 60 children with obesity, between 6 and 12 years of age, and one of their parents/legal guardians. Clinical and implementation outcomes will be assessed pre- and post-intervention, and at 8 and 12 months' follow-up. Clinical outcomes are physical activity level/pattern, BMI, waist circumference, metabolic risk markers (blood pressure, fasting plasma glucose, high- and low-density lipoprotein cholesterol, insulin resistance, and triglycerides), quality of life, self-efficacy and motivation for physical activity, and intervention satisfaction. Implementation outcomes are the four core constructs of the Normalization Process Theory; coherence, cognitive participation, collective action, and reflexive monitoring; appropriateness, acceptability and feasibility of the PAP intervention; barriers and facilitators for implementing PAP; recruitment and attrition rates, and intervention fidelity and adherence.

The clinical study is nested in a larger research project employing a hybrid implementation-effectiveness design. Design and analysis of the included studies is guided by the Normalization Process Theory.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Pre-trial phase/healthcare practitioner:
  • Inclusion criteria:
  • - being a healthcare practitioner or manager involved in the treatment of children with obesity at a paediatric healthcare clinic in Region Västra Götaland
  • Clinical trial/patients:
  • Inclusion criteria:
  • aged 6-12 years
  • diagnosed with obesity (age adjusted BMI>ISO-BMI 30)
  • having an insufficient physical activity level according to national recommendations
  • being willing to participate and perform the chosen activity/-ies
  • having a parent who is willing to participate.

排除标准

  • severe psychiatric comorbidity
  • severe intellectual or physical disability

研究组 & 干预措施

Physical activity on prescription

Experimental

Physical activity on prescription is a behaviour change intervention comprising 3 components: a person-centred pre-intervention dialogue, a written prescription for individually tailored physical activity, and a structured follow-up.

干预措施: Physical activity on prescription (PAP) (Behavioral)

结局指标

主要结局

Change in physical activity level

时间窗: 4, 8, 12 months after baseline

Change in time spent in moderate to vigorous physical activity, measured with accelerometry

次要结局

  • Change in physical activity pattern(4, 8, 12 months after baseline)
  • Intervention acceptability(Post-intervention at 4 months)
  • Change in systolic and diastolic blood pressure(Baseline to 12 months)
  • Change in fasting plasma glucose(Baseline to 12 months)
  • Change in triglycerides(Baseline to 12 months)
  • Change in high- and low-density lipoprotein cholesterol(Baseline to 12 months)
  • Change in BMI(4, 8, 12 months after baseline)
  • Change in self-efficacy for physical activity(4, 8, 12 months after baseline)
  • Change in Hemoglobin A1C (HbA1C)(Baseline to 12 months)
  • Change in motivation for physical activity(4, 8, 12 months after baseline)
  • Change in health-related quality of life(4, 8, 12 months after baseline)
  • Change in fasting P-insulin(Baseline to 12 months)

研究者

发起方
Vastra Gotaland Region
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Susanne Bernhardsson

Principal investigator, Research and Development Strategist, R&D primary health care

Vastra Gotaland Region

研究点 (1)

Loading locations...

相似试验